These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

772 related items for PubMed ID: 29156182

  • 1. Obesity Pharmacotherapy.
    Saunders KH, Umashanker D, Igel LI, Kumar RB, Aronne LJ.
    Med Clin North Am; 2018 Jan; 102(1):135-148. PubMed ID: 29156182
    [Abstract] [Full Text] [Related]

  • 2. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis.
    Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ, Loomba R, Camilleri M, Singh S.
    JAMA; 2016 Jun 14; 315(22):2424-34. PubMed ID: 27299618
    [Abstract] [Full Text] [Related]

  • 3. Drug treatment of obesity: current status and future prospects.
    Kakkar AK, Dahiya N.
    Eur J Intern Med; 2015 Mar 14; 26(2):89-94. PubMed ID: 25634851
    [Abstract] [Full Text] [Related]

  • 4. Overview of new antiobesity drugs.
    Hainer V.
    Expert Opin Pharmacother; 2014 Oct 14; 15(14):1975-8. PubMed ID: 25100293
    [Abstract] [Full Text] [Related]

  • 5. Long-term effects of weight-reducing drugs in people with hypertension.
    Siebenhofer A, Winterholer S, Jeitler K, Horvath K, Berghold A, Krenn C, Semlitsch T.
    Cochrane Database Syst Rev; 2021 Jan 17; 1(1):CD007654. PubMed ID: 33454957
    [Abstract] [Full Text] [Related]

  • 6. Current and emerging pharmacotherapies for obesity in Australia.
    Hocking S, Dear A, Cowley MA.
    Obes Res Clin Pract; 2017 Jan 17; 11(5):501-521. PubMed ID: 28818558
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. New antiobesity agents: lorcaserin (Belviq) and phentermine/topiramate ER (Qsymia).
    Shyh G, Cheng-Lai A.
    Cardiol Rev; 2014 Jan 17; 22(1):43-50. PubMed ID: 24304809
    [Abstract] [Full Text] [Related]

  • 10. Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand?
    Tak YJ, Lee SY.
    Curr Obes Rep; 2021 Mar 17; 10(1):14-30. PubMed ID: 33410104
    [Abstract] [Full Text] [Related]

  • 11. Obesity Epidemic: Pharmaceutical Weight Loss.
    Curry SA.
    R I Med J (2013); 2017 Mar 01; 100(2):18-20. PubMed ID: 28246654
    [Abstract] [Full Text] [Related]

  • 12. Lorcaserin, phentermine topiramate combination, and naltrexone bupropion combination for weight loss: the 15-min challenge to sort these agents out.
    Citrome L.
    Int J Clin Pract; 2014 Dec 01; 68(12):1401-5. PubMed ID: 25418525
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacotherapy for obesity in individuals with type 2 diabetes.
    Chukir T, Shukla AP, Saunders KH, Aronne LJ.
    Expert Opin Pharmacother; 2018 Feb 01; 19(3):223-231. PubMed ID: 29376439
    [Abstract] [Full Text] [Related]

  • 14. Drug treatment of obesity in the cardiovascular patient.
    Charakida M, Tousoulis D, Finer N.
    Curr Opin Cardiol; 2013 Sep 01; 28(5):584-91. PubMed ID: 23928924
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacotherapy for obesity: What you need to know.
    Bersoux S, Byun TH, Chaliki SS, Poole KG.
    Cleve Clin J Med; 2017 Dec 01; 84(12):951-958. PubMed ID: 29244650
    [Abstract] [Full Text] [Related]

  • 17. Pharmacotherapy of Obesity: Clinical Trials to Clinical Practice.
    Gadde KM, Pritham Raj Y.
    Curr Diab Rep; 2017 May 01; 17(5):34. PubMed ID: 28378293
    [Abstract] [Full Text] [Related]

  • 18. A Comparison of New Pharmacological Agents for the Treatment of Obesity.
    Nuffer W, Trujillo JM, Megyeri J.
    Ann Pharmacother; 2016 May 01; 50(5):376-88. PubMed ID: 26887340
    [Abstract] [Full Text] [Related]

  • 19. Medications for Obesity: A Review.
    Gudzune KA, Kushner RF.
    JAMA; 2024 Aug 20; 332(7):571-584. PubMed ID: 39037780
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.